Mary T. Szela, Director at Coherus BioSciences, Inc. (CHRS), sold 109,994 shares at $17.58 ($1.9M) on 2020-06-22, disclosed to the SEC on 2020-06-24.
Open-market sale of $1.9M CHRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.58 | 54,997 | $967K | 50.0% |
| 2 | $17.58 | 54,997 | $967K | 50.0% |
| Total | $17.58 avg | 109,994 | $1.9M | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |